Aspreva to Present at the BioCentury NewsMakers in the Biotech
Industry Conference in New York

VICTORIA, BC, Sept. 2 Aspreva
Pharmaceuticals
Corporation (NASDAQ: ASPV; TSX: ASV) today announced that Noel Hall,
Aspreva's
Co-Founder and President will present at the BioCentury NewsMakers
in the
Biotech Industry Conference in New York.
The 25-minute presentation followed by a 1 hour breakout session
will
take place on Friday September 9, 2005 at 1:20 pm EDT at the
Sheraton New York
Hotel and Towers in New York.
A live audio webcast of Mr. Hall's presentation will be
available to all
interested parties through a link posted on Aspreva's website at
www.aspreva.com in the Investors section.

About Aspreva Pharmaceuticals
Aspreva is an emerging pharmaceutical company focused on
identifying,
developing and upon regulatory approval, commercializing new
indications for
approved drugs and late stage drug candidates for less common
diseases.
Aspreva's "indication partnering" strategy allows its partners to
maintain
core brand focus while extending the benefits of their medicines to
a broader
patient population. Aspreva is listed on the Nasdaq National Market
under the
trading symbol "ASPV" and on the Toronto Stock Exchange under the
trading
symbol "ASV".

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech